Tiny study probes link between heart output and anesthesia reversal
NCT ID NCT04619225
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether the heart's pumping ability affects how quickly patients recover from muscle relaxants given during surgery. Researchers measured heart output and recovery time after using sugammadex to reverse the relaxant rocuronium. Only 7 people took part before the study was stopped early, so the findings are very limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- sugammadex
- What this could lead to
- If successful, this could help doctors predict recovery time from muscle relaxants based on heart function, potentially improving anesthesia care.
- What could go wrong
- This was a very small, terminated study with only 7 participants. Results may not be reliable or apply to broader populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESIDUAL NEUROMUSCULAR BLOCKADE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32223, United States